Last reviewed · How we verify

NCT07410390

Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

Not yet recruiting NA Last updated 13 February 2026
What this trial tests

NA trial testing bipolar resection of the prostate in Benign Prostatic Hyperplasia With Outflow Obstruction in 105 participants. Not yet recruiting.

Timeline
20 February 2026
Primary endpoint
20 December 2026
30 December 2026

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment105
Start date20 February 2026
Primary completion20 December 2026
Estimated completion30 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 55 to 85, male only, with Benign Prostatic Hyperplasia With Outflow Obstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized Controlled Study Comparing Safety, Efficacy and Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Benign Prostatic Hyperplasia With Outflow Obstruction

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07410390.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing